Sulbutiamine Reference

Plain English

What it is

Sulbutiamine is a man-made form of vitamin B1 (thiamine) built to dissolve in fat so it reaches the brain more easily than ordinary thiamine. It is not approved by the FDA as a drug in the United States. In France it is sold as a medicine (brand name Arcalion) for ongoing tiredness and weakness, a condition doctors there call functional asthenia.

What people use it for

In nootropic and online communities people reach for it as a mental-energy or anti-fatigue lift that feels more clear-headed than a stimulant. Some combine it with other brain supplements.

What the science shows

The human evidence is weak. The largest careful trial, in people with long-lasting tiredness after an infection, found no real difference from a dummy pill overall, and an early short-lived benefit faded by the study's end. Claims that it reliably sharpens thinking or memory are largely unproven.

The catch

Reports describe a fading effect and a pull toward ever-larger amounts, and there are published cases of addiction and of worsened bipolar disorder, which makes it especially concerning for anyone with a history of bipolar-type mood swings. Reported side effects include agitation, insomnia, headache, tremor, and a racing heartbeat. In the US the FDA has said sulbutiamine does not qualify as a lawful dietary supplement ingredient and has warned a company for selling it as one, so US 'supplement' products containing it sit outside what the FDA considers legal.

Reference summary

Sulbutiamine is a lipophilic synthetic thiamine dimer that crosses the blood-brain barrier more readily than thiamine and elevates brain thiamine pyrophosphate. French clinical literature in functional asthenia, most notably the Tiev 1999 (Rev Med Interne) and Loo 1992 trials, reports modest short-course improvement on subjective fatigue endpoints, with effect sizes that decay quickly on continued use as tolerance builds. Smaller trials in postinfectious fatigue and chemotherapy-related asthenia are mixed. Hypomania, irritability, and withdrawal-like rebound have been reported in case literature, and the French label limits course length accordingly.

Regulatory and posture

Categories

Nootropic

Aliases

Arcalion, Bisibutiamine, Enerion, Isobutyryl thiamine disulfide

Evidence posture

human - Not FDA-approved in the US. French non-US approval for functional asthenia. Tolerance reportedly builds quickly with daily use; the French label caps course length. Hypomania and irritability case reports are concerning in users with a bipolar-spectrum history.

Regulatory status

No FDA-approved sulbutiamine drug label in the US. Approved in France (Arcalion) and several non-US markets (notably Vietnam and parts of West Africa) for functional asthenia. Sold as a dietary supplement in some markets, including the US, where it has no FDA-approved drug label.

Content review status

research reference